Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
3.210
+0.420 (15.05%)
At close: Nov 20, 2024, 4:00 PM
3.190
-0.020 (-0.62%)
Pre-market: Nov 21, 2024, 7:13 AM EST

Inotiv Revenue

Inotiv had revenue of $105.79M in the quarter ending June 30, 2024, a decrease of -32.82%. This brings the company's revenue in the last twelve months to $501.06M, down -13.93% year-over-year. In the fiscal year ending September 30, 2023, Inotiv had annual revenue of $572.43M with 4.52% growth.

Revenue (ttm)
$501.06M
Revenue Growth
-13.93%
P/S Ratio
0.17
Revenue / Employee
$243,826
Employees
2,055
Market Cap
83.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023572.43M24.77M4.52%
Sep 30, 2022547.66M458.05M511.19%
Sep 30, 202189.61M29.14M48.18%
Sep 30, 202060.47M16.85M38.64%
Sep 30, 201943.62M17.27M65.55%
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OptimizeRx 88.18M
MDxHealth 84.71M
BioAtla 11.00M
Armata Pharmaceuticals 5.47M
Werewolf Therapeutics 3.39M
Vistagen Therapeutics 876.00K
Ovid Therapeutics 631.70K
Revenue Rankings